These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 24206191

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C, Ottl J.
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [Abstract] [Full Text] [Related]

  • 3. Novel trends in high-throughput screening.
    Mayr LM, Bojanic D.
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Using label-free screening technology to improve efficiency in drug discovery.
    Halai R, Cooper MA.
    Expert Opin Drug Discov; 2012 Feb; 7(2):123-31. PubMed ID: 22468914
    [Abstract] [Full Text] [Related]

  • 8. Virtual compound screening in drug discovery.
    Stumpfe D, Ripphausen P, Bajorath J.
    Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679
    [Abstract] [Full Text] [Related]

  • 9. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A, Keserű GM.
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [Abstract] [Full Text] [Related]

  • 10. Riboswitch-based antibacterial drug discovery using high-throughput screening methods.
    Penchovsky R, Stoilova CC.
    Expert Opin Drug Discov; 2013 Jan; 8(1):65-82. PubMed ID: 23163232
    [Abstract] [Full Text] [Related]

  • 11. Non-stoichiometric inhibition in integrated lead finding - a literature review.
    Klumpp M.
    Expert Opin Drug Discov; 2016 Jan; 11(2):149-62. PubMed ID: 26653534
    [Abstract] [Full Text] [Related]

  • 12. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S, Hadian K.
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [Abstract] [Full Text] [Related]

  • 13. Hit finding: towards 'smarter' approaches.
    Langer T, Hoffmann R, Bryant S, Lesur B.
    Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Strategies to generate biological reagents for kinase drug discovery.
    Hassan NJ, Gul S.
    Expert Opin Drug Discov; 2011 Dec; 6(12):1215-25. PubMed ID: 22647062
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. How far can virtual screening take us in drug discovery?
    Kar S, Roy K.
    Expert Opin Drug Discov; 2013 Mar; 8(3):245-61. PubMed ID: 23330660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.